The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans
Status:
Completed
Trial end date:
2020-01-13
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the mass balance and routes of excretion of total
radioactivity after a single oral 30mg (100µCi) dose of [14C] HQP1351 given as a suspension.
For further clinical development, human mass balance data are required to elucidate the
absorption, metabolism, and excretion of HQP1351.